Star Health & Allied Insurance Company Ltd

- There is no specific mention of any current or future fundraising through debt or equity in the transcript. - The management focuses primarily on profitable growth, improving loss ratios, and operational efficiencies. - Discussions revolve around strategy, underwriting, pricing, GST impact, and business mix rather than fundraising plans. - No guidance or indication regarding raising new capital via debt or equity has been provided during the call.

The transcript does not explicitly mention any current or future capex, capital investment, or strategic investment plans by Star Health and Allied Insurance Company Ltd. However, there are some relevant points indicating ongoing investments in technology and business initiatives: - Significant progress in enhancing digital experience including implementation of a new claims platform migrating 40% of claims traffic. - Launch of an AI-enabled in-house claims platform to improve productivity, customer satisfaction, and fraud detection. - Introduction of a new in-house developed agency app for sales advisors. - Development and expansion of the in-house customer app, which has reached 12 million downloads. - Expansion of wellness-related activities including home healthcare presence growth to 250+ cities and 121% growth in daily medicine facilities. These imply ongoing strategic investments mainly in IT infrastructure, digital platforms, and wellness services for long-term sustainable growth. No specific capex figures or future large-scale capital investments are disclosed.

- Encouraging improvement in loss ratio in Q2 signals positive trend for growth. - GST exemption on retail health insurance expected to provide strong tailwinds, boosting demand and affordability. - Fresh business growth robust, with about 50% growth in new policies noted in October. - Retail health business focus with preferred geographies showing 1.5x faster growth than company average. - Long-term policies growing significantly; about 13% of policies are long-term with higher value contribution (35-40%). - Digital channels growing rapidly (~47% YoY fresh premium growth), contributing 20% of fresh business. - Agency channel remains strong, with 20% growth in fresh business and expanding agent base (~8 lakh agents). - Continuous portfolio recalibration and pricing discipline expected to support profitable growth. - Persistency improving (200-300 bps increase in renewals), aiding retention and sustainable volume growth. - Management confident of positive NEP growth excluding group business decline.

- The company is focused on a long-term strategy to improve Return on Equity (RoE), targeting mid-teens RoE by 2027-2028. - Gradual improvement in underwriting loss and combined ratios is expected, with positive trends observed in Q2 FY2026. - Efforts like premium increases, portfolio recalibration, better underwriting, and fraud control are contributing to improving loss ratios. - Persistency improvements and premium increases aligned with medical inflation will support earnings growth. - Net Earned Premium (NEP) growth is stable and improving, especially in retail health, with long-term plan contributions rising. - The removal of GST on retail health policies and commission cost optimizations are expected to positively impact profitability. - Investment yields remain healthy (~8.3%) supporting overall earnings. - IFRS PAT grew 21% YoY in H1 FY2026, reflecting robust profit growth momentum. - Digital initiatives and wellness offerings are expected to enhance growth and operational efficiency over time.

The transcript from the Star Health and Allied Insurance Company Ltd. Q2 FY2026 earnings call does not provide specific information on the company's current or expected order book or pending orders. The discussion mainly focuses on: - Loss ratio improvement and guidance - Impact of GST on commissions and pricing - New business growth, especially retail health and long-term policies - Customer retention and renewal persistency - Digital and agency channel performance - Operational efficiency, underwriting, and fraud control initiatives No mention is made of order books or pending orders as it is an insurance company, where such terminology is typically not applicable.